Top Markets
Coin of the day
Zynerba Pharmaceuticals, Inc. Zynerba Pharmaceuticals, Inc.

Zynerba Pharmaceuticals, Inc.

ZYNE
Classement en actions #26763
Zynerba Pharmaceuticals, Inc. is a specialized pharmaceutical firm currently in... Zynerba Pharmaceuticals, Inc. is a specialized pharmaceutical firm currently in the clinical development phase. Its primary objective is to create and advance medicinal transdermal cannabinoid treatments specifically for uncommon and scarcely encountered neuropsychiatric conditions. A key product in its pipeline is Zygel, a pharmaceutical-grade cannabidiol expertly crafted into a gel with enhanced skin penetration for topical application. Originally established as AllTranz, Inc., the company adopted its current name, Zynerba Pharmaceuticals, Inc., in August 2014. Founded in 2007, Zynerba Pharmaceuticals maintains its headquarters in Devon, Pennsylvania.
Prix de l'action
$1.30
Dernière synchronisation: 2023-10-13
Capitalisation boursière
$38.02M
Changement (1 jour)
0.00%
Changement (1 an)
0.00%
Pays
US
Échange Zynerba Pharmaceuticals, Inc. (ZYNE)

Catégorie

Historique du prix de l'action pour Zynerba Pharmaceuticals, Inc. (ZYNE)
Prix de clôture le plus élevé : $1.27 le 2023-10-01

Prix de clôture le plus bas : $28.18 le 2015-08-01
Historique du prix de l'action de Zynerba Pharmaceuticals, Inc. de 2015 à 2026
Performance annuelle du prix de l'action
Année Performance
2023 121.20%
2022 -82.15%
2021 -16.92%
2020 -34.43%
2019 51.25%
2018 -67.91%
2017 -17.16%
2016 20.03%
2015 0.00%
Prix de l'action pour des entreprises similaires ou concurrentes
Entreprise Prix de l'action Variation 1a% Pays
$171.67 -
DE
$162.33 24.77%
DE
$38.00 22.72%
JP
$221.55 33.82%
CH
$21.01 11.96%
IN